These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Global programme to eliminate lymphatic filariasis: progress report for 2012. Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461 [No Abstract] [Full Text] [Related]
7. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667 [No Abstract] [Full Text] [Related]
10. Conclusions of the meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, November 2007. Wkly Epidemiol Rec; 2008 Sep; 83(37):341-7. PubMed ID: 18788147 [No Abstract] [Full Text] [Related]
13. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis. Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883 [TBL] [Abstract][Full Text] [Related]
14. The development of albendazole for lymphatic filariasis. Horton J Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396 [TBL] [Abstract][Full Text] [Related]
15. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007). Hooper PJ; Bradley MH; Biswas G; Ottesen EA Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394 [TBL] [Abstract][Full Text] [Related]